Lung Cancer

Matthew D. Hellmann MD and Heather Wakelee MD review and share their expert perspectives on key lung cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • Recurrent MPM: Nivo ± Ipi
    MAPS-2 (IFCT-1501): Nivolumab ± Ipilimumab in Recurrent Malignant Pleural Mesothelioma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology